NATO Allied Joint Medical Publication 7: Allied Joint Medical Doctrine for Support to Chemical, Biological, Radiological, and Nuclear (CBRN) Defensive Operations, Final Draft
INSTITUTE FOR DEFENSE ANALYSES ALEXANDRIA VA
Pagination or Media Count:
Chemical, biological, radiological and nuclear CBRN weapons produce battlefield conditions not found in conventional warfare. The presence of contaminants, the types and times of injuries, and the scale of CBRN weapon effects are such that conventional planning processes will be inadequate to address the CBRN challenge. The consideration of the unique aspects of CBRN conditions on the medical planning process is such that a clearly articulated doctrine is required to enable medical support to CBRN defensive operations. The aim of AJMedP-7, Allied Joint Medical Doctrine for Support to CBRN Defensive Operations, is to bridge the foundational medical support doctrine in AJP 4.10, Allied Joint Medical Support Doctrine, and the specific requirements for medical support to CBRN defensive operations now found within advisory and technical publications. This publication is principally for use by North Atlantic Treaty Organization NATO commanders and their medical staffs in the planning and conduct of medical support operations for which there is an assessed risk of intentional or accidental use of CBRN substances.
- Medicine and Medical Research
- Chemical, Biological and Radiological Warfare